Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 pseudogene 8 (MTND4P8)
- Target
- MTND4P8
- Molecular classification
- Other (pseudogene)
01
Overview
MTND4P8 is a genomic DNA sequence in the human nuclear genome classified as a **pseudogene** of the mitochondrial MT-ND4 gene. While the original MT-ND4 gene encodes a subunit of mitochondrial NADH:ubiquinone oxidoreductase (Complex I), MTND4P8 does not encode a protein and has no known biological function. Pseudogenes such as MTND4P8 are considered non-functional remnants of gene duplication or transfer events and are not considered therapeutic targets. Unlike the functional MT-ND4 protein, which has disease associations, MTND4P8 has not been implicated in any disease, nor are there any known drugs, biomarkers, or safety concerns related to this pseudogene. If searching for a true molecular target related to **NADH:ubiquinone oxidoreductase**, the correct entity is the **MT-ND4** protein, not MTND4P8.
- Other names
- MTND4P8MT-ND4 Pseudogene 8
02
Mechanism of action
None. There is no mechanism of action relevant for drugs, as it is a non-functional pseudogene
03
Biological functions
None established. MTND4P8, as a pseudogene, does not have known biological function or encode a protein
04
Disease associations
None established. There is no evidence that this pseudogene plays a direct role in disease processes. Note: Mutations in the protein-coding MT-ND4 gene (not the pseudogene) are linked with Leber hereditary optic neuropathy and other conditions, but the pseudogene itself is not implicated
05
Safety considerations
None associated directly. MTND4P8 has no known therapeutic relevance, and thus no specific safety concerns
06
Interacting drugs
None. No drugs are known to interact with MTND4P8, as it is a non-functional pseudogene
07
Biomarkers
None. MTND4P8 is not used as a biomarker for patient selection or efficacy monitoring
Beyond the preview
Go deeper on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 pseudogene 8 (MTND4P8).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 pseudogene 8 (MTND4P8).